ACRO BIOMEDICAL CO., LTD. Cash and Restricted Cash
ACRO BIOMEDICAL CO., LTD. (ACBM) had Cash and Restricted Cash of $3.65 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.65K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.87K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.10K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.32K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $3.65K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.87K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $4.10K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $4.32K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $26.00 10-Q · filed 2026-08-14 |
| 2025-03-31 | $251.00 10-Q · filed 2026-05-05 |
| 2024-12-31 | $476.00 10-Q · filed 2026-08-14 |
| 2024-09-30 | $701.00 10-Q · filed 2025-11-10 |
| 2024-06-30 | $926.00 10-Q · filed 2025-08-05 |
| 2024-03-31 | $151.00 10-Q · filed 2025-07-24 |
| 2023-12-31 | $376.00 10-K · filed 2026-02-11 |
| 2023-09-30 | $3.27K 10-Q · filed 2025-07-23 |
| 2023-06-30 | $2.68K 10-Q · filed 2025-07-23 |
| 2023-03-31 | $322.00 10-Q · filed 2025-07-22 |
| 2022-12-31 | $5.85K 10-K · filed 2025-07-24 |
| 2022-09-30 | $16.19K 10-Q · filed 2025-07-11 |
| 2022-06-30 | $12.11K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $357.67K 10-Q · filed 2023-08-02 |
| 2021-12-31 | $95.25K 10-K · filed 2025-07-18 |
| 2021-09-30 | $154.66K 10-Q · filed 2022-11-21 |
| 2020-12-31 | $18.12K 10-K · filed 2023-07-21 |